Thi Dan Linh Nguyen-Kim, MD

Original Contribution

Transcatheter Aortic Valve Implantation (TAVI) Outcome According to Standardized Endpoint Definitions by the Valve Academic Research Consortium (VARC)

07/28/2011

Andre Plass , MD;

Volkmar Falk , MD;

Thomas F. Lascher , MD;

Roberto Corti , MD;

Barbara E. Stahli , MD;

Lukas A. Altwegg , MD;

Willibald Maier , MD;

J. Gruenenfelder , MD;

Christian Felix , MD;

Dominique Bettex , MD;

Patric Biaggi , MD;

Felix C. Tanner , MD;

Thi Dan Linh Nguyen-Kim , MD;

ABSTRACT: Background. Transcatheter aortic valve implantation (TAVI) has become an accepted treatment option for severe aortic stenosis (AS) in high-risk individuals. Yet, current results are difficult to compare given the lack of...

ABSTRACT: Background. Transcatheter aortic valve implantation (TAVI) has become an accepted treatment option for severe aortic stenosis (AS) in high-risk individuals. Yet, current results are difficult to compare given the lack of...

ABSTRACT: Background....

07/28/2011

Journal of Invasive Cardiology

Transcatheter Aortic Valve-In-Valve Implantation: Clinical Outcome as Defined by VARC-2 and Postprocedural Valve Dysfunction According to the Primary Mode of Bioprosthesis Failure

09/27/2014

Roberto Corti , MD;

Hanna Tasnady , BSc;

Thomas Frauenfelder , MD;

Michael J. Mullen , MD;

Barbara E. Stahli , MD;

Catherine Gebhard , MD;

Willibald Maier , MD;

J. Gruenenfelder , MD;

Thi Dan Linh Nguyen-Kim , MD;

Ulf Landmesser , MD;

Volkmar Falk , MD;

Thomas F. Lascher , MD;

Surgical aortic valve replacement (SAVR) is considered the standard treatment for symptomatic aortic stenosis (AS) due to its excellent short- and long-term outcomes. The present study reports the University of Zurich and the University...

Surgical aortic valve replacement (SAVR) is considered the standard treatment for symptomatic aortic stenosis (AS) due to its excellent short- and long-term outcomes. The present study reports the University of Zurich and the University...

Surgical aortic valve...

09/27/2014

Journal of Invasive Cardiology

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar